The regulation of amylin and insulin gene expression and secretion

Pancreas

Volumn 30, Issue 1, 2005, Pages 1-14

  Cluck, Michael W ^a   Chan, Chung Y ^b   Adrian, Thomas E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; AMYLIN; ARGININE; CALCIUM; CYCLIC AMP; GLUCOSE; GLUTAMINE; GUANOSINE TRIPHOSPHATASE; INSULIN; LEUCINE; POTASSIUM CHANNEL;

CALCIUM TRANSPORT; EXOCYTOSIS; GENE CONTROL; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HOMEOSTASIS; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; INSULIN RELEASE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECRETORY VESICLE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

AMYLOID; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN-SECRETING CELLS;

EID: 11244311563     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (240)

1. Inagaki N, Tsuura Y, Namba N, et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem. 1995;270:5691-5694.
2. Inagaki N, Gonoi T, Clement JPt, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270:1166-1170.
3. Sakura H, Ammala C, Smith PA, et al. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle. FEBS Lett. 1995;377:338-344.
4. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67-113.
5. Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature. 1984;312:446-448.
6. Cook DL, Hales CN. Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature. 1984;311:271-273.
7. Ghosh A, Ronner P, Cheong E, et al. The role of ATP and free ADP in metabolic coupling during fuel-stimulated insulin release from islet beta-cells in the isolated perfused rat pancreas. J Biol Chem. 1991;266:22887-22892.
8. Prentki M, Tornheim K, Corkey BE. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia. 1997;40(suppl 2):S32-S41.
9. Tucker SJ, Gribble FM, Zhao C, et al. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature. 1997;387:179-183.
10. Tanabe K, Tucker SJ, Matsuo M, et al. Direct photoaffinity labeling of the Kir6.2 subunit of the ATP-sensitive K+ channel by 8-azido-ATP. J Biol Chem. 1999;274:3931-3933.
11. Wang C, Wang K, Wang W, et al. Compromised ATP binding as a mechanism of phosphoinositide modulation of ATP-sensitive K+ channels. FEBS Lett. 2002;532:177-182.
12. Shyng S, Ferrigni T, Nichols CG. Regulation of KATP channel activity by diazoxide and MgADP. Distinct functions of the two nucleotide binding folds of the sulfonylurea receptor. J Gen Physiol. 1997;110:643-654.
13. Gribble FM, Tucker SJ, Haug T, et al. MgATP activates the beta cell KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A. 1998;95:7185-7190.
14. Matsuo M, Tanabe K, Kioka N, et al. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B. J Biol Chem. 2000;275:28757-28763.
15. Hopkins WF, Fatherazi S, Peter-Riesch B, et al. Two sites for adenine-nucleotide regulation of ATP-sensitive potassium channels in mouse pancreatic beta-cells and HIT cells. J Membr Biol. 1992;129:287-295.
16. Ashcroft FM, Rorsman P. ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion. Biochem Soc Trans. 1990;18:109-111.
17. Sener A, Best LC, Yates AP, et al. Stimulus-secretion coupling of arginine-induced insulin release: comparison between the cationic amino acid and its methyl ester. Endocrine. 2000;13:329-340.
18. Cartier EA, Conti LR, Vandenberg CA, et al. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc Natl Acad Sci U S A. 2001;98:2882-2887.
19. Partridge CJ, Beech DJ, Sivaprasadarao A. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism. J Biol Chem. 2001;276:35947-35952.
20. Taschenberger G, Mougey A, Shen S, et al. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels. J Biol Chem. 2002;277:17139-17146.
21. Nestorowicz A, Inagaki N, Gonoi T, et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes. 1997;46:1743-1748.
22. Nichols CG, Shyng SL, Nestorowicz A, et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science. 1996;272:1785-1787.
23. Huopio H, Reimann F, Ashfield R, et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest. 2000;106:897-906.
24. Inoue H, Ferrer J, Welling CM, et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes. 1996;45:825-831.
25. Hart LM, de Knijff P, Dekker JM, et al. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with type II diabetes mellitus in Dutch Caucasians. Diabetologia. 1999;42:617-620.
26. Rissanen J, Markkanen A, Karkkainen P, et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care. 2000;23:70-73.
27. Hani EH, Boutin P, Durand E, et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia. 1998;41:1511-1515.
28. Stirling B, Cox NJ, Bell GI, et al. Linkage studies in NIDDM with markers near the sulphonylurea receptor gene. Diabetologia. 1995;38:1479-1481.
29. Iwasaki N, Kawamura M, Yamagata K, et al. Identification of microsatellite markers near the human genes encoding the beta-cell ATP-sensitive K+ channel and linkage studies with NIDDM in Japanese. Diabetes. 1996;45:267-269.
30. Sakura H, Wat N, Horton V, et al. Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia. 1996;39:1233-1236.
31. Lindner T, Gragnoli C, Schulze J, et al. The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes. 1997;46:1227-1229.
32. Miki T, Nagashima K, Tashiro F, et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci U S A. 1998;95:10402-10406.
33. Seino S, Iwanaga T, Nagashima K, et al. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes. 2000;49:311-318.
34. Dunne MJ, Kane C, Shepherd RM, et al. Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med. 1997;336:703-706.
35. Kane C, Shepherd RM, Squires PE, et al. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat Med. 1996;2:1344-1347.
36. Seghers V, Nakazaki M, DeMayo F, et al. Sur 1 knockout mice. A model for K(ATP) channel-independent regulation of insulin secretion. J Biol Chem. 2000;275:9270-9277.
37. Cook DL, Taborsky GJ. In: Porte D, Sherwin RS, eds. Elleberg and Rifkin's Diabetes Mellitus, 5th ed. Stamford, CT: Appleton and Lange, 1997:49-73.
38. Atwater I, Mears D, Rojas E. Diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus. Philadelphia: Lippincott-Raven, 1996:78-102.
39. Keahey HH, Rajan AS, Boyd AE 3rd, et al. Characterization of voltage-dependent Ca2+ channels in beta-cell line. Diabetes. 1989;38:188-193.
40. Hiriart M, Matteson DR. Na channels and two types of Ca channels in rat pancreatic B cells identified with the reverse hemolytic plaque assay. J Gen Physiol. 1988;91:617-639.
41. Bhattacharjee A, Whitehurst RM Jr, Zhang M, et al. T-type calcium channels facilitate insulin secretion by enhancing general excitability in the insulin-secreting beta-cell line, INS-1. Endocrinology. 1997;138:3735-3740.
42. Misler S, Barnett DW, Gillis KD, et al. Electrophysiology of stimulus-secretion coupling in human beta-cells. Diabetes. 1992;41:1221-1228.
43. Devis G, Somers G, Van Obberghen E, et al. Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil. Diabetes. 1975;24:247-251.
44. Bokvist K, Eliasson L, Ammala C, et al. Co-localization of L-type Ca2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. EMBO J. 1995;14:50-57.
45. Seino S, Chen L, Seino M, et al. Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells. Proc Natl Acad Sci U S A. 1992;89:584-588.
46. Horvath A, Szabadkai G, Varnai P, et al. Voltage dependent calcium channels in adrenal glomerulosa cells and in insulin producing cells. Cell Calcium. 1998;23:33-42.
47. Liu G, Dilmac N, Hilliard N, et al. Ca v 1.3 is preferentially coupled to glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. J Pharmacol Exp Ther. 2003;305:271-278.
48. Schulla V, Renstrom E, Feil R, et al. Impaired insulin secretion and glucose tolerance in beta cell-selective Ca(v) 1.2 Ca2+ channel null mice. EMBO J. 2003;22:3844-3854.
49. Namkung Y, Skrypnyk N, Jeong MJ, et al. Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. J Clin Invest. 2001;108:1015-1022.
50. Sato Y, Aizawa T, Komatsu M, et al. Dual functional role of membrane depolarization/Ca2+ influx in rat pancreatic B-cell. Diabetes. 1992;41:438-443.
51. Gembal M, Gilon P, Henquin JC. Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest. 1992;89:1288-1295.
52. Komatsu M, Schermerhorn T, Aizawa T, et al. Glucose stimulation of insulin release in the absence of extracellular Ca2+ and in the absence of any increase in intracellular Ca2+ in rat pancreatic islets. Proc Natl Acad Sci U S A. 1995;92:10728-10732.
53. Prentki MV, Brun S, Glennon T, et al. Metabolic Coupling Factors in Beta Cell Insulin Secretion. Washington, DC: Elsevier, 1991:156-160.
54. Brun T, Roche E, Assimacopoulos-Jeannet F, et al. Evidence for an anaplerotic/malonyl-CoA pathway in pancreatic beta-cell nutrient signaling. Diabetes. 1996;45:190-198.
55. Roche E, Farfari S, Witters LA, et al. Long-term exposure of beta-INS cells to high glucose concentrations increases anaplerosis, lipogenesis, and lipogenic gene expression. Diabetes. 1998;47:1086-1094.
56. Chen S, Ogawa A, Ohneda M, et al. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes. 1994;43:878-883.
57. Zhang S, Kim KH. Essential role of acetyl-CoA carboxylase in the glucose-induced insulin secretion in a pancreatic beta-cell line. Cell Signal. 1998;10:35-42.
58. Prentki M, Vischer S, Glennon MC, et al. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem. 1992;267:5802-5810.
59. Yonemoto W, McGlone ML, Taylor SS. N-myristylation of the catalytic subunit of cAMP-dependent protein kinase conveys structural stability. J Biol Chem. 1993;268:2348-2352.
60. MacDonald MJ, Kaysen JH, Moran SM, et al. Pyruvate dehydrogenase and pyruvate carboxylase. Sites of pretranslational regulation by glucose of glucose-induced insulin release in pancreatic islets. J Biol Chem. 1991;266:22392-22397.
61. Brun T, Roche E, Kim KH, et al. Glucose regulates acetyl-CoA carboxylase gene expression in a pancreatic beta-cell line (INS-1). J Biol Chem. 1993;268:18905-18911.
62. Gromada J, Rorsman P, Dissing S, et al. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release. FEBS Lett. 1995;373:182-186.
63. Ammala C, Ashcroft FM, Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. Nature. 1993;363:356-358.
64. Jones PM, Fyles JM, Howell SL. Regulation of insulin secretion by cAMP in rat islets of Langerhans permeabilised by high-voltage discharge. FEBS Lett. 1986;205:205-209.
65. Ding WG, Gromada J. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide. Diabetes. 1997;46:615-621.
66. Gromada J, Bokvist K, Ding WG, et al. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes. 1998;47:57-65.
67. Dachicourt N, Serradas P, Giroix MH, et al. Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP. Am J Physiol. 1996;271:E725-E732.
68. Yada T, Sakurada M, Ihida K, et al. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem. 1994;269:1290-1293.
69. Straub SG, Sharp GW. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J Biol Chem. 1996;271:1660-1668.
70. Easom RA, Landt M, Colca JR, et al. Effects of insulin secretagogues on protein kinase C-catalyzed phosphorylation of an endogenous substrate in isolated pancreatic islets. J Biol Chem. 1990;265:14938-14946.
71. Robertson RP, Tsai P, Little SA, et al. Receptor-mediated adenylate cyclase-coupled mechanism for PGE2 inhibition of insulin secretion in HIT cells. Diabetes. 1987;36:1047-1053.
72. Fehmann HC, Janssen M, Goke B. Interaction of glucagon-like peptide-I (GLP-1) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells. Acta Diabetol. 1995;32:176-181.
73. McDermott AM, Sharp GW. Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell. Diabetes. 1995;44:453-459.
74. Sollner TH, Rothman JE. Molecular machinery mediating vesicle budding, docking and fusion. Experientia. 1996;52:1021-1025.
75. Sollner T, Whiteheart SW, Brunner M, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993;362:318-324.
76. Sutton RB, Fasshauer D, Jahn R, et al. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature. 1998;395:347-353.
77. Geppert M, Goda Y, Hammer RE, et al. Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell. 1994;79:717-727.
78. Bruns D, Jahn R. Molecular determinants of exocytosis. Pflugers Arch. 2002;443:333-338.
79. Jacobsson G, Bean AJ, Scheller RH, et al. Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells. Proc Natl Acad Sci U S A. 1994;91:12487-12491.
80. Sadoul K, Lang J, Montecucco C, et al. SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J Cell Biol. 1995;128:1019-1028.
81. Wheeler MB, Sheu L, Ghai M, et al. Characterization of SNARE protein expression in beta cell lines and pancreatic islets. Endocrinology. 1996;137:1340-1348.
82. Nagamatsu S, Nakamichi Y, Katahira H. Syntaxin, but not soluble NSF attachment protein (SNAP), biosynthesis by rat pancreatic islets is regulated by glucose in parallel with proinsulin biosynthesis. Diabetologia. 1997;40:1396-1402.
83. Regazzi R, Wollheim CB, Lang J, et al. VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca(2+)-but not for GTP gamma S-induced insulin secretion. EMBO J. 1995;14:2723-2730.
84. Mizuta M, Kurose T, Miki T, et al. Localization and functional role of synaptotagmin III in insulin secretory vesicles in pancreatic beta-cells. Diabetes. 1997;46:2002-2006.
85. Sheu L, Pasyk EA, Ji J, et al. Regulation of insulin exocytosis by Munc13-1. J Biol Chem. 2003;278:27556-27563.
86. Olofsson CS, Gopel SO, Barg S, et al. Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells. Pflugers Arch. 2002;444:43-51.
87. Barg S, Ma X, Eliasson L, et al. Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophys J. 2001;81:3308-3323.
88. Barg S, Eliasson L, Renstrom E, et al. A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse beta-cells. Diabetes. 2002;51(suppl 1):S74-S82.
89. Gromada J, Hoy M, Renstrom E, et al. CaM kinase II-dependent mobilization of secretory granules underlies acetylcholine-induced stimulation of exocytosis in mouse pancreatic B-cells. J Physiol. 1999;518:745-759.
90. Barg S, Olofsson CS, Schriever-Abeln J, et al. Delay between fusion pore opening and peptide release from large dense-core vesicles in neuroendocrine cells. Neuron. 2002;33:287-299.
91. Hay JC, Martin TF. Resolution of regulated secretion into sequential MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins. J Cell Biol. 1992;119:139-151.
92. Rorsman P, Eliasson L, Renstrom E, et al. The cell physiology of biphasic insulin secretion. News Physiol Sci. 2000;15:72-77.
93. Barg S, Huang P, Eliasson L, et al. Priming of insulin granules for exocytosis by granular Cl(-) uptake and acidification. J Cell Sci. 2001;114:2145-2154.
94. Wollheim CBL, Regazzi J. R. The exocytotic process of insulin secretion and its regulation by Ca2+ and G-proteins. Diabetes Rev. 1996;4:277-297.
95. Lang J, Ushkaryov Y, Grasso A, et al. Ca 2+-independent insulin exocytosis induced by alpha-latrotoxin requires latrophilin, a G protein-coupled receptor. EMBO J. 1998;17:648-657.
96. Komatsu M, Schermerhorn T, Noda M, et al. Augmentation of insulin release by glucose in the absence of extracellular Ca2+: new insights into stimulus-secretion coupling. Diabetes. 1997;46:1928-1938.
97. Lang J, Nishimoto I, Okamoto T, et al. Direct control of exocytosis by receptor-mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits. EMBO J. 1995;14:3635-3644.
98. Kowluru A, Seavey SE, Li G, et al. Glucose- and GTP-dependent stimulation of the carboxyl methylation of CDC42 in rodent and human pancreatic islets and pure beta cells. Evidence for an essential role of GTP-binding proteins in nutrient-induced insulin secretion. J Clin Invest. 1996;98:540-555.
99. Regazzi R, Ravazzola M, Iezzi M, et al. Expression, localization and functional role of small GTPases of the Rab3 family in insulin-secreting cells. J Cell Sci. 1996;109:2265-2273.
100. de Rooij J, Zwartkruis FJ, Verheijen MH, et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998;396:474-477.
101. Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMP-binding proteins that directly activate Rap1. Science. 1998;282:2275-2279.
102. Kashima Y, Miki T, Shibasaki T, et al. Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem. 2001;276:46046-46053.
103. Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000;2:805-811.
104. Holz GG. Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes. 2004;53:5-13.
105. Eliasson L, Ma X, Renstrom E, et al. SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells. J Gen Physiol. 2003;121:181-197.
106. Shibasaki T, Sunaga Y, Fujimoto K, et al. Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent Ca2+ channel in insulin granule exocytosis. J Biol Chem. 2004;279:7956-7961.
107. Clark A, Edwards CA, Ostle LR, et al. Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tissue Res. 1989;257:179-185.
108. Lukinius A, Wilander E, Westermark GT, et al. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia. 1989;32:240-244.
109. Kahn SE, D'Alessio DA, Schwartz MW, et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes. 1990;39:634-638.
110. Krampert M, Bernhagen J, Schmucker J, et al. Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP). Chem Biol. 2000;7:855-871.
111. Badman MK, Shennan KI, Jermany JL, et al. Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. FEBS Lett. 1996;378:227-231.
112. Wang J, Xu J, Finnerty J, et al. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes. 2001;50:534-539.
113. Higham CE, Hull RL, Lawrie L, et al. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur J Biochem. 2000;267:4998-5004.
114. Marzban L, Trigo-Gonzalez G, Zhu X, et al. Role of beta-cell prohormone convertase (PC) 1/3 in processing of pro-islet amyloid polypeptide. Diabetes. 2004;53:141-148.
115. Glenner GG, Eanes ED, Wiley CA. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochem Biophys Res Commun. 1988;155:608-614.
116. Goldsbury CS, Cooper GJ, Goldie KN, et al. Polymorphic fibrillar assembly of human amylin. J Struct Biol. 1997;119:17-27.
117. Goldsbury C, Kistler J, Aebi U, et al. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol. 1999;285:33-39.
118. Goldsbury C, Goldie K, Pellaud J, et al. Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol. 2000;130:352-362.
119. Larson JL, Ko E, Miranker AD. Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry. Protein Sci. 2000;9:427-431.
120. Jaikaran ET, Higham CE, Serpell LC, et al. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol. 2001;308:515-525.
121. Nilsson MR, Raleigh DP. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J Mol Biol. 1999;294:1375-1385.
122. Nilsson MR, Nguyen LL, Raleigh DP. Synthesis and purification of amyloidogenic peptides. Anal Biochem. 2001;288:76-82.
123. MacArthur MW, Thornton JM. Influence of proline residues on protein conformation. J Mol Biol. 1991;218:397-412.
124. Minor DL Jr, Kim PS. Measurement of the beta-sheet-forming propensities of amino acids. Nature. 1994;367:660-663.
125. Moriarty DF, Raleigh DP. Effects of sequential proline substitutions on amyloid formation by human amylin20-29. Biochemistry. 1999;38:1811-1818.
126. Soto C, Kindy MS, Baumann M, et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun. 1996;226:672-680.
127. Westermark P, Engstrom U, Johnson KH, et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A. 1990;87:5036-5040.
128. Nishi M, Chan SJ, Nagamatsu S, et al. Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci U S A. 1989;86:5738-5742.
129. Betsholtz C, Christmansson L, Engstrom U, et al. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 1989;251:261-264.
130. Soeller WC, Janson J, Hart SE, et al. Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes. 1998;47:743-750.
131. Lorenzo A, Razzaboni B, Weir GC, et al. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994;368:756-760.
132. Mirzabekov TA, Lin MC, Kagan BL. Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem. 1996;271:1988-1992.
133. Hoppener JW, Ahren B, Lips CJ. Islet amyloid and type 2 diabetes mellitus. N Engl J Med. 2000;343:411-419.
134. Hiddinga HJ, Eberhardt NL. Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. Am J Pathol. 1999;154:1077-1088.
135. Schubert D, Behl C, Lesley R, et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A. 1995;92:1989-1993.
136. Janciauskiene S, Ahren B. Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RINm5F cells. Biochem Biophys Res Commun. 1998;251:888-893.
137. Zhang S, Liu J, Saafi EL, et al. Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1/CIP1. FEBS Lett. 1999;455:315-320.
138. Kawahara M, Kuroda Y, Arispe N, et al. Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem. 2000;275:14077-14083.
139. Kourie JI, Shorthouse AA. Properties of cytotoxic peptide-formed ion channels. Am J Physiol Cell Physiol. 2000;278:C1063-C1087.
140. Sakagashira S, Hiddinga HJ, Tateishi K, et al. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol. 2000;157:2101-2109.
141. Zhang S, Liu J, MacGibbon G, et al. Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells. J Mol Biol. 2002;324:271-285.
142. Anguiano M, Nowak RJ, Lansbury PT Jr. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry. 2002;41:11338-11343.
143. Butler AE, Janson J, Soeller WC, et al. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes. 2003;52:2304-2314.
144. Stridsberg M, Sandler S, Wilander E. Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of beta-cell function. Regul Pept. 1993;45:363-370.
145. Larsson H, Ahren B. Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans. Pancreas. 1995;11:201-205.
146. Leckstrom A, Lundquist I, Ma Z, et al. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas. 1999;18:266-273.
147. Alam T, Chen L, Ogawa A, et al. Coordinate regulation of amylin and insulin expression in response to hypoglycemia and fasting. Diabetes. 1992;41:508-514.
148. Gedulin B, Cooper GJ, Young AA. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochem Biophys Res Commun. 1991;180:782-789.
149. O'Brien TD, Westermark P, Johnson KH. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes. 1991;40:1701-1706.
150. Couce M, Kane LA, O'Brien TD, et al. Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction. Diabetes. 1996;45:1094-1101.
151. Wang F, Larsson J, Abdiu A, et al. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol. 1997;21:157-164.
152. Ding X, Flatt PR, Permert J, et al. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology. 1998;114:130-138.
153. Enoki S, Mitsukawa T, Takemura J, et al. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;15:97-102.
154. Hanabusa T, Kubo K, Oki C, et al. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;15:89-96.
155. Permert J, Larsson J, Westermark GT, et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med. 1994;330:313-318.
156. Kautzky-Willer A, Thomaseth K, Pacini G, et al. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia. 1994;37:188-194.
157. Wang ZL, Bennet WM, Ghatei MA, et al. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes. 1993;42:330-335.
158. Silvestre RA, Salas M, Garcia-Hermida O, et al. Amylin (islet amyloid polypeptide) inhibition of insulin release in the perfused rat pancreas: implication of the adenylate cyclase/cAMP system. Regul Pept. 1994;50:193-199.
159. Furnsinn C, Leuvenink H, Roden M, et al. Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am J Physiol. 1994;267:E300-E305.
160. Sandler S, Stridsberg M. Chronic exposure of cultured rat pancreatic islets to elevated concentrations of islet amyloid polypeptide (IAPP) causes a decrease in islet DNA content and medium insulin accumulation. Regul Pept. 1994;53:103-109.
161. Gebre-Medhin S, Mulder H, Pekny M, et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun. 1998;250:271-277.
162. Karlsson E. IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion [review]. Int J Mol Med. 1999;3:577-584.
163. Nyholm B, Orskov L, Hove KY, et al. The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism. 1999;48:935-941.
164. Silvestre RA, Rodriguez-Gallardo J, Jodka C, et al. Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas. Am J Physiol Endocrinol Metab. 2001;280:E443-E449.
165. Pittner RA, Albrandt K, Beaumont K, et al. Molecular physiology of amylin. J Cell Biochem. 1994;55(suppl):19-28.
166. Pittner R, Beaumont K, Young A, et al. Dose-dependent elevation of cyclic AMP, activation of glycogen phosphorylase, and release of lactate by amylin in rat skeletal muscle. Biochim Biophys Acta. 1995;1267:75-82.
167. James JH, Wagner KR, King JK, et al. Stimulation of both aerobic glycolysis and Na(+)-K(+)-ATPase activity in skeletal muscle by epinephrine or amylin. Am J Physiol. 1999;277:E176-E186.
168. Clausen T. Effects of amylin and other peptide hormones on Na+-K+ transport and contractility in rat skeletal muscle. J Physiol. 2000;527:121-130.
169. Beaumont K, Moore CX, Pittner RA, et al. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists. Can J Physiol Pharmacol. 1995;73:1025-1029.
170. Wang F, Westermark G, Gasslander T, et al. Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets. Regul Pept. 1997;72:61-67.
171. Young AA, Carlo P, Rink TJ, et al. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol Cell Endocrinol. 1992;84:R1-R5.
172. Wang F, Adrian TE, Westermark GT, et al. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. Am J Physiol. 1999;276:E19-E24.
173. Bretherton-Watt D, Gilbey SG, Ghatei MA, et al. Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. J Clin Endocrinol Metab. 1992;74:1032-1035.
174. Mather KJ, Paradisi G, Learning R, et al. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity. Diabetes Metab Res Rev. 2002;18:118-126.
175. Clark A, de Koning EJ, Morris JF. Formation of islet amyloid from islet amyloid polypeptide. Biochem Soc Trans. 1993;21:169-173.
176. Mulder H, Ahren B, Sundler F. Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats. Am J Physiol. 1996;271:E1008-E1014.
177. Gasa R, Gomis R, Casamitjana R, et al. Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) gene expression in human pancreatic islets. Regul Pept. 1997;68:99-104.
178. Bretherton-Watt D, Ghatei MA, Bloom SR, et al. Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia. 1989;32:881-883.
179. Novials A, Sarri Y, Casamitjana R, et al. Regulation of islet amyloid
180. Gasa R, Gomis R, Casamitjana R, et al. High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas. 2001;22:307-310.
181. Hou X, Ling Z, Quartier E, et al. Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors. Diabetologia. 1999;42:188-194.
182. Huang HJ, Young AA, Koda JE, et al. Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats. Hypertension. 1992;19:I101-I109.
183. Mulder H, Ahren B, Stridsberg M, et al. Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment. Diabetologia. 1995;38:395-402.
184. Mulder H, Ahren B, Sundler F. Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats. J Endocrinol. 1997;152:495-501.
185. Koranyi L, James DE, Kraegen EW, et al. Feedback inhibition of insulin gene expression by insulin. J Clin Invest. 1992;89:432-436.
186. Koranyi L, Tanizawa Y, Penicaud L, et al. Developmental regulation of amylin and insulin-gene expression in lean (Fa/Fa) and obese (fa/fa) Zucker rats. Diabetes. 1992;41:685-690.
187. Giddings SJ, Carnaghi LR, Mooradian AD. Age-related changes in pancreatic islet cell gene expression. Metabolism. 1995;44:320-324.
188. Ding WQ, Holicky E, Miller LJ. Glucose and forskolin regulate IAPP gene expression through different signal transduction pathways. Am J Physiol Endocrinol Metab. 2001;281:E938-E945.
189. Cluck MW, Murphy LO, Olson J, et al. Amylin gene expression mediated by cAMP/PKA and transcription factors HNF-1 and NFY. Mol Cell Endocrinol. 2003;210:63-75.
190. Kakita K, Giddings S, Permutt MA. Biosynthesis of rat insulins I and II: evidence for differential expression of the two genes. Proc Natl Acad Sci U S A. 1982;79:2803-2807.
191. German M, Ashcroft S, Docherty K, et al. The insulin gene promoter. A simplified nomenclature. Diabetes. 1995;44:1002-1004.
192. Moss LG, Moss JB, Rutter WJ. Systematic binding analysis of the insulin gene transcription control region: insulin and immunoglobulin enhancers utilize similar transactivators. Mol Cell Biol. 1988;8:2620-2627.
193. Ohlsson H, Karlsson O, Edlund T. A beta-cell-specific protein binds to the two major regulatory sequences of the insulin gene enhancer. Proc Natl Acad Sci U S A. 1988;85:4228-4231.
194. Karlsson O, Walker MD, Rutter WJ, et al. Individual protein-binding domains of the insulin gene enhancer positively activate beta-cell-specific transcription. Mol Cell Biol. 1989;9:823-827.
195. Ohlsson H, Thor S, Edlund T. Novel insulin promoter- and enhancer-binding proteins that discriminate between pancreatic alpha- and beta-cells. Mol Endocrinol. 1991;5:897-904.
196. German MS, Blanar MA, Nelson C, et al. Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer. Mol Endocrinol. 1991;5:292-299.
197. Robinson GL, Cordle SR, Henderson E, et al. Isolation and characterization of a novel transcription factor that binds to and activates insulin control element-mediated expression. Mol Cell Biol. 1994;14:6704-6714.
198. Dumonteil E, Laser B, Constant I, et al. Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2. J Biol Chem. 1998;273:19945-19954.
199. Vierra CA, Nelson C. The Pan basic helix-loop-helix proteins are required for insulin gene expression. Mol Endocrinol. 1995;9:64-71.
200. German MS, Moss LG, Wang J, et al. The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes. Mol Cell Biol. 1992;12:1777-1788.
201. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 1993;12:4251-4259.
202. Peers B, Leonard J, Sharma S, et al. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol Endocrinol. 1994;8:1798-1806.
203. Macfarlane WM, Smith SB, James RF, et al. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells. J Biol Chem. 1997;272:20936-20944.
204. Macfarlane WM, Shepherd RM, Cosgrove KE, et al. Glucose modulation of insulin mRNA levels is dependent on transcription factor PDX-1 and occurs independently of changes in intracellular Ca2+. Diabetes. 2000;49:418-423.
205. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 1994;371:606-609.
206. Serup P, Petersen HV, Pedersen EE, et al. The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site. Biochem J. 1995;310:997-1003.
207. Hui H, Wright C, Perfetti R. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes. 2001;50:785-796.
208. Melloul D, Ben-Neriah Y, Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci U S A. 1993;90:3865-3869.
209. Marshak S, Totary H, Cerasi E, et al. Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci U S A. 1996:93:15057-15062.
210. Patane G, Kaneto H, Toschi E, et al. Induction of Mad expression leads to augmentation of insulin gene transcription. Biochem Biophys Res Commun. 2003;303:1199-1208.
211. Kaneto H, Sharma A, Suzuma K, et al. Induction of c-Myc expression suppresses insulin gene transcription by inhibiting NeuroD/BETA2-mediated transcriptional activation. J Biol Chem. 2002;277:12998-13006.
212. Karlsson O, Edlund T, Moss JB, et al. A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc Natl Acad Sci U S A. 1987;84:8819-8823.
213. Watada H, Mirmira RG, Leung J, et al. Transcriptional and translational regulation of beta-cell differentiation factor Nkx6.1. J Biol Chem. 2000;275:34224-34230.
214. Kennedy GC, Rutter WJ. Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells. Proc Natl Acad Sci U S A. 1992;89:11498-11502.
215. Oetjen E, Diedrich T, Eggers A, et al. Distinct properties of the cAMP-responsive element of the rat insulin I gene. J Biol Chem. 1994;269:27036-27044.
216. Matsuoka TA, Zhao L, Artner I, et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol Cell Biol. 2003;23:6049-6062.
217. Crowe DT, Tsai MJ. Mutagenesis of the rat insulin II 5′-flanking region defines sequences important for expression in HIT cells. Mol Cell Biol. 1989;9:1784-1789.
218. Shieh SY, Tsai MJ. Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. J Biol Chem. 1991;266:16708-16714.
219. Peyton M, Moss LG, Tsai MJ. Two distinct class A helix-loop-helix transcription factors, E2A and BETA1, form separate DNA binding complexes on the insulin gene E box. J Biol Chem. 1994;269:25936-25941.
220. Ling Z, Heimberg H, Foriers A, et al. Differential expression of rat insulin I and II messenger ribonucleic acid after prolonged exposure of islet beta-cells to elevated glucose levels. Endocrinology. 1998;139:491-495.
221. Lu M, Seufert J, Habener JF. Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem. 1997;272:28349-28359.
222. Campbell SC, Cragg H, Elrick LJ, et al. Inhibitory effect of pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters. FEBS Lett. 1999;463:53-57.
223. Brink C, Chowdhury K, Gruss P. Pax4 regulatory elements mediate beta cell specific expression in the pancreas. Mech Dev. 2001;100:37-43.
224. Smith SB, Watada H, Scheel DW, et al. Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter. J Biol Chem. 2000;275:36910-36919.
225. Sander M, Neubuser A, Kalamaras J, et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 1997;11:1662-1673.
226. Wice BM, Bernal-Mizrachi E, Permutt MA. Glucose and other insulin secretagogues induce, rather than inhibit, expression of Id-1 and Id-3 in pancreatic islet beta cells. Diabetologia. 2001;44:453-463.
227. Kang Y, Huang X, Pasyk EA, et al. Syntaxin- 3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines. Diabetologia. 2002;45:231-241.
228. van Mansfeld AD, Mosselman S, Hoppener JW, et al. Islet amyloid polypeptide: structure and upstream sequences of the IAPP gene in rat and man. Biochim Biophys Acta. 1990;1087:235-240.
229. De Wit L, van Mansfeld AD, van Teeffelen HA, et al. Strong promoter activity of human and rat islet amyloid polypeptide/amylin gene constructs in mouse beta cells (beta TC 3). Biochem Biophys Res Commun. 1993;192:840-848.
230. Bretherton-Watt D, Gore N, Boam DS. Insulin upstream factor 1 and a novel ubiquitous factor bind to the human islet amyloid polypeptide/amylin gene promoter. Biochem J. 1996;313:495-502.
231. Carty MD, Lillquist JS, Peshavaria M, et al. Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells. J Biol Chem. 1997;272:11986-11993.
232. Watada H, Kajimoto Y, Kaneto H, et al. Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem Biophys Res Commun. 1996;229:746-751.
233. Macfarlane WM, Campbell SC, Elrick LJ, et al. Glucose regulates islet amyloid polypeptide gene transcription in a PDX1- and calcium-dependent manner. J Biol Chem. 2000;275:15330-15335.
234. Serup P, Jensen J, Andersen FG, et al. Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc Natl Acad Sci U S A. 1996;93:9015-9020.
235. Roy AL, Meisteremst M, Pognonec P, et al. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature. 1991;354:245-248.
236. Mosselman S, Hoppener JW, de Wit L, et al. IAPP/amylin gene transcriptional control region: evidence for negative regulation. FEBS Lett. 1990;271:33-36.
237. Wang M, Drucker DJ. Activation of amylin gene transcription by LIM domain homeobox gene isl-1. Mol Endocrinol. 1996;10:243-251.
238. Vallejo M, Penchuk L, Habener JF. Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl-1-like, and alpha-CBF-like transcription factors. J Biol Chem. 1992;267:12876-12884.
239. Leonard J, Serup P, Gonzalez G, et al. The LIM family transcription factor Isl-1 requires cAMP response element binding protein to promote somatostatin expression in pancreatic islet cells. Proc Natl Acad Sci U S A. 1992;89:6247-6251.
240. Ilag LL, Tabaei BP, Herman WH, et al. Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes. 2000;49:961-968.